Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Tong Han

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 2 papers

Papers 4

  1. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration. Co-author DOI 10.1002/jcp.27039↗
  2. Long noncoding RNA FEZF1-AS1 predicts poor prognosis and modulates pancreatic cancer cell proliferation and invasion through miR-142/HIF-1α and miR-133a/EGFR u… Co-author DOI 10.1002/jcp.28188↗
  3. MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9. Co-author DOI 10.3892/mmr.2015.3294↗
  4. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway. First author DOI 10.3892/mmr.2015.3380↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhenglin Ou · 2 shared papers, 2019 · strength 0.21
  2. Zhen Luo · 2 shared papers, 2019 · strength 0.21
  3. LI Yi-xiong · 2 shared papers, 2015 · strength 0.13
  4. Xiaoping Yi · 2 shared papers, 2015 · strength 0.13
  5. Yebin Lu · 1 shared paper, 2019 · strength 0.11
  6. Min Zhang · 1 shared paper, 2019 · strength 0.11
  7. Yixiong Li · 1 shared paper, 2019 · strength 0.11
  8. Feizhou Huang · 1 shared paper, 2019 · strength 0.10
  9. Mujing Ke · 1 shared paper, 2015 · strength 0.06
  10. Wenzheng Li · 1 shared paper, 2015 · strength 0.06
  11. Bo Liu · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.